Literature DB >> 25503371

Inflammation and cognitive functioning in African Americans and Caucasians.

Felicia C Goldstein1, Liping Zhao2, Kyle Steenland2, Allan I Levey1.   

Abstract

OBJECTIVE: To examine associations between inflammation and cognitive performance in African Americans and Caucasians.
METHODS: The sample included 59 African Americans and 219 Caucasians ≥  50 years old who had a baseline visit at the Emory/Georgia Tech Center for Health Discovery and Well Being. Peripheral levels of inflammation (interleukin-6, interleukin-8, C-reactive protein, and tumor necrosis factor-α) were examined in relation to performance on tests of visual processing (Identify the Odd Pattern), attention (Digit Span Forward), visuomotor set shifting (Digit Symbol Substitution), verbal set shifting (Digit Span Backwards), and memory (Recall a Pattern).
RESULTS: Multiple regression models adjusting for potential demographic and vascular/metabolic confounders were conducted, with markers of inflammation included as either continuous or categorical (quartiles) variables. There were significant interactions between IL-8 and race for the Recall a Pattern (p = .006) and the Digit Symbol Substitution (p = .014) tests. Race-specific analyses (using a continuous variable for IL-8) demonstrated slower response times on the Recall a Pattern and Digit Symbol Substitution tests for African Americans but not for Caucasians. Categorical analyses among African Americans indicated that all of the top three quartiles of IL-8 were associated with slower reaction times on the Recall a Pattern test compared to the lowest quartile, while for Digit Symbol, the highest quartile of IL-8 was associated with the slowest cognitive performance.
CONCLUSIONS: These preliminary findings suggest a stronger association between IL-8 and cognitive performance in African Americans than Caucasians. This relationship should be further examined in larger samples that are followed over time.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  African Americans; cognition; cytokines; inflammation; race

Mesh:

Substances:

Year:  2014        PMID: 25503371      PMCID: PMC4682666          DOI: 10.1002/gps.4238

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  32 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  2010 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

3.  Integrating comparative effectiveness research programs into predictive health: a unique role for academic health centers.

Authors:  Kimberly J Rask; Kenneth L Brigham; Michael M E Johns
Journal:  Acad Med       Date:  2011-06       Impact factor: 6.893

4.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

Authors:  Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider
Journal:  Arch Neurol       Date:  2003-02

5.  Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers.

Authors:  Anna L Marsland; Karen L Petersen; Rama Sathanoori; Matthew F Muldoon; Serina A Neumann; Christopher Ryan; Janine D Flory; Stephen B Manuck
Journal:  Psychosom Med       Date:  2006 Nov-Dec       Impact factor: 4.312

6.  Inflammatory markers and cognition in well-functioning African-American and white elders.

Authors:  K Yaffe; K Lindquist; B W Penninx; E M Simonsick; M Pahor; S Kritchevsky; L Launer; L Kuller; S Rubin; T Harris
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

Review 8.  Predictive health: the imminent revolution in health care.

Authors:  Kenneth L Brigham
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

9.  Inflammation and rate of cognitive change in high-functioning older adults.

Authors:  Dawn E Alley; Eileen M Crimmins; Arun Karlamangla; Peifeng Hu; Teresa E Seeman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-01       Impact factor: 6.053

10.  Markers of inflammation and cognitive decline in an African-Caribbean population.

Authors:  Vesna Jordanova; Robert Stewart; Emma Davies; Roy Sherwood; Martin Prince
Journal:  Int J Geriatr Psychiatry       Date:  2007-10       Impact factor: 3.485

View more
  16 in total

1.  Cytokines are associated with longitudinal changes in cognitive performance among urban adults.

Authors:  May A Beydoun; Jordan Weiss; Hardeep K Obhi; Hind A Beydoun; Gregory A Dore; Hailun Liang; Michele K Evans; Alan B Zonderman
Journal:  Brain Behav Immun       Date:  2019-04-11       Impact factor: 7.217

2.  Ethnoracial differences in brain structure change and cognitive change.

Authors:  Brandon E Gavett; Evan Fletcher; Danielle Harvey; Sarah Tomaszewski Farias; John Olichney; Laurel Beckett; Charles DeCarli; Dan Mungas
Journal:  Neuropsychology       Date:  2018-04-12       Impact factor: 3.295

3.  Increased inflammation in BA21 brain tissue from African Americans with Alzheimer's disease.

Authors:  Sherry A Ferguson; Vijayalakshmi Varma; Daniel Sloper; John J Panos; Sumit Sarkar
Journal:  Metab Brain Dis       Date:  2019-12-10       Impact factor: 3.584

4.  Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.

Authors:  Whitney Wharton; Felicia C Goldstein; Malú G Tansey; Alexandra L Brown; Sonum D Tharwani; Danielle D Verble; Amarallys Cintron; Patrick G Kehoe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans.

Authors:  Sherry A Ferguson; John J Panos; Daniel Sloper; Vijayalakshmi Varma; Sumit Sarkar
Journal:  Metab Brain Dis       Date:  2021-05-22       Impact factor: 3.584

6.  Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.

Authors:  Geana Paula Kurita; Ola Ekholm; Stein Kaasa; Pål Klepstad; Frank Skorpen; Per Sjøgren
Journal:  Brain Behav       Date:  2016-05-03       Impact factor: 2.708

7.  Normobaric hypoxia overnight impairs cognitive reaction time.

Authors:  Stephan Pramsohler; Stefan Wimmer; Martin Kopp; Hannes Gatterer; Martin Faulhaber; Martin Burtscher; Nikolaus Cristoph Netzer
Journal:  BMC Neurosci       Date:  2017-05-15       Impact factor: 3.288

8.  The correlation between longitudinal changes in hypothalamic-pituitary-adrenal (HPA)-axis activity and changes in neurocognitive function in mixed-state bipolar II disorder.

Authors:  Hsuan-Han Lee; Cheng-Ho Chang; Liang-Jen Wang; Chih-Ching Wu; Hsing-Ling Chen; Ti Lu; Ru-Band Lu; Sheng-Yu Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-15       Impact factor: 2.570

9.  Inflammatory markers and tract-based structural connectomics in older adults with a preliminary exploration of associations by race.

Authors:  Elizabeth A Boots; Liang Zhan; Karla J Castellanos; Lisa L Barnes; Lisa Tussing-Humphreys; Melissa Lamar
Journal:  Brain Imaging Behav       Date:  2021-07-16       Impact factor: 3.978

10.  Cognitive Changes during Prolonged Stay at High Altitude and Its Correlation with C-Reactive Protein.

Authors:  Sheng Li Hu; Wei Xiong; Zhi Qiang Dai; Heng Li Zhao; Hua Feng
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.